{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T20:22:53Z","timestamp":1787862173875,"version":"build-2784847793"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T00:00:00Z","timestamp":1560729600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T00:00:00Z","timestamp":1560729600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"University of Lincoln Research Investment Fund Grant","award":["RIF2013-51"],"award-info":[{"award-number":["RIF2013-51"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s00198-019-05045-z","type":"journal-article","created":{"date-parts":[[2019,6,18]],"date-time":"2019-06-18T11:02:32Z","timestamp":1560855752000},"page":"1845-1854","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Saving bones without risking brain\u2014bisphosphonates and risk of stroke: matched case-control study"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2564-2096","authenticated-orcid":false,"given":"Z. B.","family":"Asghar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Godoy Caballero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Pathirannehelage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"McKay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Grassby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"de Lusignan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Niroshan Siriwardena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,17]]},"reference":[{"issue":"6","key":"5045_CR1","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/aje\/kwq433","volume":"173","author":"H Quan","year":"2011","unstructured":"Quan H, Li B, Couris CM, Fushimi K, Graham P, Hider P, Januel JM, Sundararajan V (2011) Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol 173(6):676\u2013682","journal-title":"Am J Epidemiol"},{"key":"5045_CR2","volume-title":"Bisphosphonates for treating osteoporosis","author":"NICE","year":"2017","unstructured":"NICE (2017) Bisphosphonates for treating osteoporosis. National Institute for Health and Clinical Excellence, London"},{"key":"5045_CR3","volume-title":"Osteoporosis: Assessing the risk of fragility fracture","author":"NICE","year":"2012","unstructured":"NICE (2012) Osteoporosis: Assessing the risk of fragility fracture. National Institute for Health and Clinical Excellence, London"},{"issue":"11","key":"5045_CR4","doi-asserted-by":"publisher","first-page":"818","DOI":"10.7326\/M15-1361","volume":"166","author":"A Qaseem","year":"2017","unstructured":"Qaseem A, Forciea MA, McLean RM, Denberg TD, for the Clinical Guidelines Committee of the American College of Physicians (2017) Treatment of low bone density or osteoporosis to prevent fractures in men and women: a clinical practice guideline update from the American College of Physicians. Ann Intern Med 166(11):818\u2013839","journal-title":"Ann Intern Med"},{"issue":"9912","key":"5045_CR5","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/S0140-6736(13)61647-5","volume":"383","author":"IR Reid","year":"2014","unstructured":"Reid IR, Bolland MJ, Grey A (2014) Effects of vitamin D supplements on bone mineral density: a systematic review and meta-analysis. Lancet 383(9912):146\u2013155","journal-title":"Lancet"},{"issue":"15","key":"5045_CR6","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1001\/jama.2017.21640","volume":"319","author":"LC Kahwati","year":"2018","unstructured":"Kahwati LC, Weber RP, Pan H, Gourlay M, LeBlanc E, Coker-Schwimmer M, Viswanathan M (2018) Vitamin D, calcium, or combined supplementation for the primary prevention of fractures in community-dwelling adults: evidence report and systematic review for the US preventive services task force. JAMA 319(15):1600\u20131612","journal-title":"JAMA"},{"issue":"12","key":"5045_CR7","doi-asserted-by":"publisher","first-page":"856","DOI":"10.7326\/M16-1165","volume":"165","author":"M Chung","year":"2016","unstructured":"Chung M, Tang AM, Fu Z, Wang DD, Newberry SJ (2016) Calcium intake and cardiovascular disease risk: an updated systematic review and meta-analysis. Ann Intern Med 165(12):856\u2013866","journal-title":"Ann Intern Med"},{"issue":"3","key":"5045_CR8","doi-asserted-by":"publisher","first-page":"746","DOI":"10.3945\/ajcn.113.082602","volume":"100","author":"JA Ford","year":"2014","unstructured":"Ford JA et al (2014) Cardiovascular disease and vitamin D supplementation: trial analysis, systematic review, and meta-analysis. Am J Clin Nutr 100(3):746\u2013755","journal-title":"Am J Clin Nutr"},{"issue":"4","key":"5045_CR9","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s00198-010-1276-4","volume":"22","author":"P Vestergaard","year":"2011","unstructured":"Vestergaard P, Schwartz K, Pinholt EM, Rejnmark L, Mosekilde L (2011) Stroke in relation to use of raloxifene and other drugs against osteoporosis. Osteoporos Int 22(4):1037\u20131045","journal-title":"Osteoporos Int"},{"issue":"6","key":"5045_CR10","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1007\/s00198-010-1395-y","volume":"22","author":"S Christensen","year":"2011","unstructured":"Christensen S, Mehnert F, Chapurlat RD, Baron JA, S\u00f8rensen HT (2011) Oral bisphosphonates and risk of ischemic stroke: a case-control study. Osteoporos Int 22(6):1773\u20131779","journal-title":"Osteoporos Int"},{"issue":"10","key":"5045_CR11","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1007\/s00198-012-1894-0","volume":"23","author":"JH Kang","year":"2012","unstructured":"Kang JH, Keller JJ, Lin HC (2012) A population-based 2-year follow-up study on the relationship between bisphosphonates and the risk of stroke. Osteoporos Int 23(10):2551\u20132557","journal-title":"Osteoporos Int"},{"issue":"11","key":"5045_CR12","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1016\/j.amjcard.2014.03.008","volume":"113","author":"A Sharma","year":"2014","unstructured":"Sharma A, Einstein AJ, Vallakati A, Arbab-Zadeh A, Walker MD, Mukherjee D, Homel P, Borer JS, Lichstein E (2014) Risk of atrial fibrillation with use of oral and intravenous bisphosphonates. Am J Cardiol 113(11):1815\u20131821","journal-title":"Am J Cardiol"},{"issue":"4","key":"5045_CR13","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1378\/chest.13-0675","volume":"144","author":"A Sharma","year":"2013","unstructured":"Sharma A, Chatterjee S, Arbab-Zadeh A, Goyal S, Lichstein E, Ghosh J, Aikat S (2013) Risk of serious atrial fibrillation and stroke with use of bisphosphonates: evidence from a meta-analysis. Chest 144(4):1311\u20131322","journal-title":"Chest"},{"key":"5045_CR14","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.atherosclerosis.2016.06.039","volume":"252","author":"G Kranenburg","year":"2016","unstructured":"Kranenburg G, Bartstra JW, Weijmans M, de Jong PA, Mali WP, Verhaar HJ, Visseren FLJ, Spiering W (2016) Bisphosphonates for cardiovascular risk reduction: a systematic review and meta-analysis. Atherosclerosis 252:106\u2013115","journal-title":"Atherosclerosis"},{"issue":"4","key":"5045_CR15","doi-asserted-by":"publisher","first-page":"e0122646","DOI":"10.1371\/journal.pone.0122646","volume":"10","author":"DH Kim","year":"2015","unstructured":"Kim DH, Rogers JR, Fulchino LA, Kim CA, Solomon DH, Kim SC (2015) Bisphosphonates and risk of cardiovascular events: a meta-analysis. PLoS One 10(4):e0122646","journal-title":"PLoS One"},{"issue":"4","key":"5045_CR16","doi-asserted-by":"publisher","first-page":"e011092","DOI":"10.1136\/bmjopen-2016-011092","volume":"6","author":"A Correa","year":"2016","unstructured":"Correa A, Hinton W, McGovern A, van Vlymen J, Yonova I, Jones S, de Lusignan S (2016) Royal College of General Practitioners Research and Surveillance Centre (RCGP RSC) sentinel network: a cohort profile. BMJ Open 6(4):e011092","journal-title":"BMJ Open"},{"issue":"654","key":"5045_CR17","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.3399\/bjgp16X688573","volume":"67","author":"S de Lusignan","year":"2017","unstructured":"de Lusignan S, Correa A, Pathirannehelage S, Byford R, Yonova I, Elliot AJ, Lamagni T, Amirthalingam G, Pebody R, Smith G, Jones S, Rafi I (2017) RCGP Research and Surveillance Centre annual report 2014-2015: disparities in presentations to primary care. Br J Gen Pract 67(654):e29\u2013e40","journal-title":"Br J Gen Pract"},{"issue":"8","key":"5045_CR18","doi-asserted-by":"publisher","first-page":"e020282","DOI":"10.1136\/bmjopen-2017-020282","volume":"8","author":"W Hinton","year":"2018","unstructured":"Hinton W, McGovern A, Coyle R, Han TS, Sharma P, Correa A, Ferreira F, de Lusignan S (2018) Incidence and prevalence of cardiovascular disease in English primary care: a cross-sectional and follow-up study of the Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC). BMJ Open 8(8):e020282","journal-title":"BMJ Open"},{"issue":"9","key":"5045_CR19","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1093\/aje\/kwn217","volume":"168","author":"MJ Knol","year":"2008","unstructured":"Knol MJ, Vandenbroucke JP, Scott P, Egger M (2008) What do case-control studies estimate? Survey of methods and assumptions in published case-control research. Am J Epidemiol 168(9):1073\u20131081","journal-title":"Am J Epidemiol"},{"key":"5045_CR20","unstructured":"Team, R (2018) RStudio: Integrated development for R. RStudio, B. Inc., MA URL, ed"},{"key":"5045_CR21","first-page":"38","volume":"2","author":"T, T","year":"2015","unstructured":"T, T (2015) A Package for Survival Analysis in S_ version 2:38","journal-title":"A Package for Survival Analysis in S_ version"},{"key":"5045_CR22","doi-asserted-by":"publisher","unstructured":"Fitzpatrick T et al How do neurologists diagnose transient ischemic attack: a systematic review. Int J Stroke. \n                    https:\/\/doi.org\/10.1177\/1747493018816430","DOI":"10.1177\/1747493018816430"},{"key":"5045_CR23","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.2147\/CIA.S138002","volume":"12","author":"C Caffarelli","year":"2017","unstructured":"Caffarelli C, Montagnani A, Nuti R, Gonnelli S (2017) Bisphosphonates, atherosclerosis and vascular calcification: update and systematic review of clinical studies. Clin Interv Aging 12:1819\u20131828","journal-title":"Clin Interv Aging"},{"key":"5045_CR24","doi-asserted-by":"publisher","first-page":"381","DOI":"10.2147\/CLEP.S85427","volume":"7","author":"DH Christensen","year":"2015","unstructured":"Christensen DH, Horv\u00e1th-Puh\u00f3 E, Schmidt M, Christiansen CF, Pedersen L, Langdahl BL, Thomsen RW (2015) The impact of preadmission oral bisphosphonate use on 30-day mortality following stroke: a population-based cohort study of 100,043 patients. Clin Epidemiol 7:381\u2013389","journal-title":"Clin Epidemiol"},{"issue":"1","key":"5045_CR25","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s12891-017-1514-4","volume":"18","author":"J-H Park","year":"2017","unstructured":"Park J-H et al (2017) Compliance and persistence with oral bisphosphonates for the treatment of osteoporosis in female patients with rheumatoid arthritis. BMC Musculoskelet Disord 18(1):152","journal-title":"BMC Musculoskelet Disord"},{"key":"5045_CR26","doi-asserted-by":"publisher","first-page":"i264","DOI":"10.1136\/bmj.i264","volume":"352","author":"Z Paskins","year":"2016","unstructured":"Paskins Z, Warburton L (2016) Bisphosphonates beyond five years. BMJ 352:i264","journal-title":"BMJ"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-019-05045-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-019-05045-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-019-05045-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T23:25:12Z","timestamp":1592263512000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-019-05045-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,17]]},"references-count":26,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["5045"],"URL":"https:\/\/doi.org\/10.1007\/s00198-019-05045-z","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,17]]},"assertion":[{"value":"18 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}